ELTX

NASD Elicio Therapeutics, Inc
Oct 6, 2026 · 6:40 PM ET LAST TRADE Market Closed

$1.87 ↓ -0.01 (-0.53%) Trading Down from the previous close of $1.88, $0.09 below the day’s high of $1.96

YTD change
-76.51%
vs 20-day SMA
-3.72%
vs 200-day SMA
-74.64%

Price ranges

Previous day
$1.81 $1.96
open $1.93 close $1.92
-$0.01 (-0.52%)
Today
$1.86 $1.96
open $1.90 now $1.87
-$0.03 (-1.58%)
Past week
$1.77 $1.97
from $1.85 now $1.87
+$0.02 (+1.08%)
Past month
$1.71 $2.46
from $2.41 now $1.87
-$0.54 (-22.41%)
This year
$1.71 $16.00
from $7.96 now $1.87
-$6.09 (-76.51%)

Price & Performance

-8.75 (-82.01%) / 6M

$0.7236$5.78$10.84$15.90Apr 6Jul 7Oct 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 92.3% away from all-time highs of $24.39
  • ELTX is down 77% since the beginning of the year
  • ELTX is down 83% over the past 12 months
  • ELTX is down 22% over the past 1 month
  • 7% of all ELTX investors are betting against ELTX

ELTX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -82.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.43
Earnings momentum +10.4% Quarterly EPS growth
Quarterly change +10.4%

Valuation

P/E ratio N/A
Enterprise value $27.6M
Beta 2.13

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$23.5M
Debt$14.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $49.1M

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $402.98 -0.01%
MRNA Moderna, Inc. $203.21 +6.95%
RVMD Revolution Medicines, Inc. $207.68 +0.50%
ROIV Roivant Sciences Ltd. $35.78 +0.17%
BNTX BioNTech SE Sponsored ADR $97.64 +0.76%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.